Skip to content
Review

The Ubiquitin-Proteasome System: The Cell's Natural Destroyer.

Sep 2026 · Handbook of Experimental Pharmacology · 0 citations
Medicine

TL;DR

The broad regulatory functions of the UPS are highlighted in the contexts of cell cycle progression, protein quality control, immune modulation, and apoptosis, and its pathological dysregulation in cancers and neurodegenerative disorders is underscored.

View source

Similar papers

Review Open access Oct 2026

The 19S proteasome as a therapeutic target in hematologic malignancies

The biological functions of the 19S regulatory particle, its role in cancer pathogenesis, and emerging therapeutic strategies targeting 19S-associated proteins to improve outcomes in hematologic malignancies are discussed.

Idaly M. Olivas, Mayra A. Gonzalez-Henry, S. Darvishi et al. · 0 citations
Review Open access Nov 2026

Ubiquitination and Deubiquitination: From Molecular Mechanisms to Therapeutic Strategies

ABSTRACT Ubiquitination and deubiquitination are established as a reversible regulatory system controlling protein stability, localization, molecular interactions, and signaling duration. Ubiquitin is recognized not merely as a proteasomal degradation signal but as a molecular code whose output is determined by substra...

Wan-Qing Liu, Jing Zhu, Dean Guo et al. · 0 citations
Review Open access Nov 2026

Deubiquitinases in cancer: biology, mechanism, and therapeutic targeting

The ubiquitin-proteasome system (UPS) plays a central role in cellular protein homeostasis by regulating the degradation, trafficking, and activity of target proteins. Deubiquitinases (DUBs) are a crucial component of this regulatory network, catalyzing the removal of ubiquitin moieties from modified substrates to modu...

M. A. Najar, P. Modi, Raja Rajeshwari · 0 citations
Review Open access Nov 2026

Ubiquitin-specific peptidase 33 as a potential therapeutic target for homeostatic dysregulation

Ubiquitination and deubiquitination regulate protein turnover, localization and signaling. Ubiquitin-specific pep-tidase 33 (USP33) participates in these processes through substrates involved in proliferation, apoptosis, migration and treatment response. Its effects differ across malignancies and can diverge within the...

Yu-Hong Wen, Yi-Wen Wan, Bi-Sheng Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.